Cargando…

Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma

BACKGROUND: The exosomes contain many important proteins that can be used for early tumor diagnosis or patient prognosis analysis. In this study, we investigated plasma exosome-derived sentrin SUMO-specific protease 1 (SENP1) levels as a prognostic biomarker in patients with osteosarcoma. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Wu, Jian, Song, Shu, Chen, Haining, Hu, Yong, Xu, Buwei, Liu, Jinbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006461/ https://www.ncbi.nlm.nih.gov/pubmed/33791211 http://dx.doi.org/10.3389/fonc.2021.625109

Ejemplares similares

Sentrin/SUMO Specific Proteases as Novel Tissue-Selective Modulators of Vitamin D Receptor-Mediated Signaling
por: Lee, Wai-Ping, et al.
Publicado: (2014)

The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis
por: Chang, Che-Chang, et al.
Publicado: (2018)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

Author Correction: The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis
por: Chang, Che-Chang, et al.
Publicado: (2020)

MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma
por: Jiao, Dan, et al.
Publicado: (2018)

Increased susceptibility of osteoarthritis tenocytes to FasL-induced apoptosis is associated with elevated expression of Fas receptor but no alterations in the expression of Sentrin-1/SUMO-1
por: Machner, A, et al.
Publicado: (2003)

Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer
por: Yang, Jie, et al.
Publicado: (2021)

Total Chemical Synthesis of SUMO and SUMO‐Based Probes for Profiling the Activity of SUMO‐Specific Proteases
por: Mulder, Monique P. C., et al.
Publicado: (2018)

Exosomes and osteosarcoma drug resistance
por: Fu, Huichao, et al.
Publicado: (2023)

Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma
por: Pan, Yan, et al.
Publicado: (2022)

Plasma Exosome-Derived SENP1 May Be a Potential Prognostic Predictor for Melanoma
por: Hu, Hejuan, et al.
Publicado: (2021)

SUMO-specific proteases/isopeptidases: SENPs and beyond
por: Nayak, Arnab, et al.
Publicado: (2014)

Advances in the development of SUMO specific protease (SENP) inhibitors
por: Kumar, Ashutosh, et al.
Publicado: (2015)

Plasma exosomal tRNA‐derived fragments as diagnostic biomarkers in non-small cell lung cancer
por: Zheng, Baibing, et al.
Publicado: (2022)

Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma
por: Cumba Garcia, Luz M., et al.
Publicado: (2019)

Sumo-dependent substrate targeting of the SUMO protease Ulp1
por: Elmore, Zachary C, et al.
Publicado: (2011)

Exosomal Protease Cargo as Prognostic Biomarker in Colorectal Cancer
por: Yunusova, Natalia V., et al.
Publicado: (2021)

Chemical Tools and Biochemical Assays for SUMO Specific Proteases (SENPs)
por: Jia, Yuqing, et al.
Publicado: (2019)

Structural basis for the SUMO protease activity of the atypical ubiquitin-specific protease USPL1
por: Li, Ying, et al.
Publicado: (2022)

SUMO targeting of a stress-tolerant Ulp1 SUMO protease
por: Peek, Jennifer, et al.
Publicado: (2018)

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Plasma Exosomal hsa_circ_0015286 as a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer
por: Zheng, Peiming, et al.
Publicado: (2022)

Disruption of SUMO-Specific Protease 2 Induces Mitochondria Mediated Neurodegeneration
por: Fu, Jiang, et al.
Publicado: (2014)

Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism
por: Tang, Shuang, et al.
Publicado: (2013)

Transcriptional Profile and Structural Conservation of SUMO-Specific Proteases in Schistosoma mansoni
por: Pereira, Roberta Verciano, et al.
Publicado: (2012)

Extraembryonic but not embryonic SUMO-specific protease 2 is required for heart development
por: Maruyama, Eri O., et al.
Publicado: (2016)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Prognostic analysis of telangiectatic osteosarcoma of the extremities
por: Zhong, Wei, et al.
Publicado: (2023)

A Novel Microfluidic Chip for Fast, Sensitive Quantification of Plasma Extracellular Vesicles as Biomarkers in Patients With Osteosarcoma
por: Xu, Yi-Qi, et al.
Publicado: (2021)

Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Development of a tRNA-Derived Small RNA Prognostic Panel and Their Potential Functions in Osteosarcoma
por: Tang, Zhenming, et al.
Publicado: (2021)

Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
por: Morini, Martina, et al.
Publicado: (2023)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

Loss of the SUMO protease Ulp2 triggers a specific multichromosome aneuploidy
por: Ryu, Hong-Yeoul, et al.
Publicado: (2016)

Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1
por: Liu, Juan, et al.
Publicado: (2021)

Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma
por: Wang, Bangmin, et al.
Publicado: (2022)

Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer
por: Su, Quanxin, et al.
Publicado: (2021)

Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Zhang, Zhijun, et al.
Publicado: (2020)

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qos0olc3dtq6q4m0eo50nmdabp